Bank of America Begins Coverage on Hinge Health (NYSE:HNGE)

Bank of America assumed coverage on shares of Hinge Health (NYSE:HNGE) in a research note published on Monday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $42.00 price objective on the stock.

Several other research firms have also recently issued reports on HNGE. Wall Street Zen raised Hinge Health to a “hold” rating in a research report on Monday, June 2nd. Needham & Company LLC started coverage on Hinge Health in a research report on Monday. They set a “buy” rating and a $47.00 price objective for the company. Canaccord Genuity Group started coverage on Hinge Health in a research report on Monday. They issued a “buy” rating and a $52.00 target price for the company. Barclays started coverage on Hinge Health in a research report on Monday. They issued an “overweight” rating and a $43.00 target price for the company. Finally, KeyCorp started coverage on Hinge Health in a research report on Monday. They issued an “overweight” rating and a $45.00 target price for the company. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Hinge Health has an average rating of “Moderate Buy” and a consensus target price of $46.00.

Hinge Health Trading Up 5.2%

NYSE:HNGE opened at $36.65 on Monday. Hinge Health has a 1 year low of $33.42 and a 1 year high of $43.80.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.